Marinus Pharmaceuticals Inc. (MRNS) Dropped -13.5% or -1.35 To Price $8.65 On Monday


Marinus Pharmaceuticals Inc. (MRNS) dropped -13.5% or -1.35 to $8.65. It is approximately 2.04 million shares traded, which is 326.94% compare to the average total volume 624510. The market cap of MRNS is $350.54 million. The year to date change is 5.55%. The 52 week price range is from $3.31 to $10.54. Price of MRNS have changed 11.23% during last week. It have changed 57.98% over last month, 41.64% over last 3 months, 182.49% over last 6 months and 78.89% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for MRNS is 6.93. It is -19.88% below current price. The 200-day Moving Averages for MRNS is 6.31. It is -27.05% below current price. The 52-week High is 10.54. It is 21.85% from the current price. The 52-week Low is 3.31. It is -61.73% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of MRNS is 11.2 on 2018-09-14. Short % to float is 9.45%. There are some statistics of MRNS. It is has market cap $350.54 million. The share outstanding is 40.53 million. The average volume is 624510. The percent of top 15 Institution holding is 45.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of MRNS is -79.16%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of MRNS is -68.49%.


Tags:

Share this post